N
NewsBrief
Health

Experimental weight loss jab Retatrutide outperforms Mounjaro in new study

NewsBrief AI Editorial TeamPublished 1h ago
Experimental weight loss jab Retatrutide outperforms Mounjaro in new study

Quick Brief

A recent study reveals that an experimental weight loss injection called Retatrutide demonstrates superior performance compared to Mounjaro. Clinical findings indicate the new jab could assist individuals in losing nearly a quarter of their body weight.

What Happened?

A new research study evaluated the effectiveness of the experimental weight loss injection Retatrutide, finding that it outperforms existing treatments like Mounjaro by enabling patients to lose nearly 25 per cent of their body weight.

Why It Matters

The findings highlight significant advancements in pharmacological weight management, offering a potentially more potent alternative for individuals struggling with obesity compared to currently available treatments like Mounjaro.

Key Facts

  • Retatrutide is an experimental weight loss injection.
  • The latest study shows it outperforms Mounjaro.
  • Patients could lose almost 25 per cent of their body weight using the jab.

Compiled from 1 outlet

Related Stories